AU2019902942A0 - Vaccination methods and compositions - Google Patents

Vaccination methods and compositions

Info

Publication number
AU2019902942A0
AU2019902942A0 AU2019902942A AU2019902942A AU2019902942A0 AU 2019902942 A0 AU2019902942 A0 AU 2019902942A0 AU 2019902942 A AU2019902942 A AU 2019902942A AU 2019902942 A AU2019902942 A AU 2019902942A AU 2019902942 A0 AU2019902942 A0 AU 2019902942A0
Authority
AU
Australia
Prior art keywords
compositions
vaccination methods
vaccination
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2019902942A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2019902942A0 publication Critical patent/AU2019902942A0/en
Withdrawn legal-status Critical Current

Links

AU2019902942A 2019-08-14 Vaccination methods and compositions Withdrawn AU2019902942A0 (en)

Publications (1)

Publication Number Publication Date
AU2019902942A0 true AU2019902942A0 (en) 2019-08-29

Family

ID=

Similar Documents

Publication Publication Date Title
EP3823673A4 (en) Anti-cd112r compositions and methods
EP3917497A4 (en) Oligonucleotide compositions and methods thereof
EP3891284A4 (en) Oligonucleotide compositions and methods thereof
EP3765608A4 (en) Gene-regulating compositions and methods for improved immunotherapy
EP3765094A4 (en) Gene-regulating compositions and methods for improved immunotherapy
EP3600325A4 (en) Novel compositions and methods
EP3735224A4 (en) Compositions comprising co-selected microbiota and methods for use thereof
EP3765092A4 (en) Gene-regulating compositions and methods for improved immunotherapy
EP3773718A4 (en) Compositions and methods comprising anti-nrp2 antibodies
EP3900741A4 (en) Samrna vaccine and preparation method therefor
EP3844500A4 (en) Rp182 compositions and methods
EP3843729A4 (en) Novel compositions and methods
EP3917546A4 (en) Gene-regulating compositions and methods for improved immunotherapy
EP3773654A4 (en) Polypharmaceutical drug compositions and related methods
EP4058062A4 (en) Compositions and methods for immunotherapy
EP3830109A4 (en) Methods and compositions for alphavirus vaccine
EP3927372A4 (en) Optimized vaccine compositions and methods for making the same
EP4058035A4 (en) Compositions and methods for immunotherapy
EP4051017A4 (en) Probiotic compositions and methods
EP3962512A4 (en) Immunomodulatory compositions and methods
EP3921335A4 (en) Compositions and methods involving layilin
EP3818245A4 (en) Cement compositions and methods
EP3917320A4 (en) Bacterialcidal methods and compositions
EP4003936A4 (en) Whitening methods and compositions
EP3866830A4 (en) Vaccine polypeptide compositions and methods